Science Business

Science Business: A Critical Analysis of Biotechnology's Promise and Reality. The biotechnology industry has long been touted as a revolutionary force in healthcare and medicine, but despite its promise, it has struggled to deliver on its potential. In this insightful critique, Gary P. Pisano examines the underlying causes of the industry's problems and offers a comprehensive analysis of how it works. Pisano identifies three key business challenges facing biotech firms: financing highly risky investments, learning rapidly enough to keep pace with advances in drug science knowledge, and integrating capabilities across a broad spectrum of scientific and technological expertise. To overcome these challenges, Pisano argues that industry players must adopt business models, organisational structures, and financing arrangements that prioritize long-term learning and integration over short-term 'monetisation' of intellectual property. By understanding the underlying issues facing the biotechnology industry, readers can gain a deeper insight into its potential for improvement and the steps that need to be taken to unlock its full potential.